Indication: Sculptra^® (injectable poly-L-lactic acid (PLLA-SCA)) is indicated for use in people with healthy immune systems for the correction of shallow to deep nasolabial fold contour deficiencies, fine lines and wrinkles in the cheek region, and other facial wrinkles.

Galderma will present data from across its broad Injectable Aesthetics portfolio at the International Master Course on Aging Science (IMCAS) 2026 World Congress in Paris, France, from January 29-31, 2026.

Zug, Switzerland – March 13, 2024 – Galderma Group AG, the pure-play dermatology category leader, today announces the publication of its prospectus and the start of the book-building process, as part of its intention to conduct an Initial Public Offering on the SIX Swiss Exchange.

Vevey, Switzerland,May 28, 2014 - On 11th February 2014, Nestlé announced it would extend its activities to include the field of specialised medical skin treatments through the creation of Nestlé Skin Health S.A., a global leader focused on meeting the world’s increasing skin health needs with a broad range of innovative and scientifically-proven products.